A lower-cost insulin manufacturer has taken the next step toward establishing a location in West Virginia. UNDBIO, a South Korean company, has secured a lease with West Virginia University to build an ...

Differentiating stem cells into high-quality insulin-producing cells on a large scale for therapeutic manufacturing is a common bottleneck in translational research. In a study published in Stem Cell ...

LANSING, Mich. (WLNS) – The Eaton County Board of Commissioners took the first step in suing insulin manufacturers over allegations of price fixing. Commissioner Jacob Toomey tells 6 News a resolution ...

SACRAMENTO — California is diving into the prescription drug business, attempting to achieve what no other state has done: produce its own brand of generic insulin and sell it at below-market prices ...

MORGANTOWN W.Va. – South Korean drug manufacturer UNDBIO has signed a Memorandum of Understanding pledging to manufacture insulin in West Virginia. The letter indicates there are plans to locate the ...

Two years ago, California made a bold announcement that it would manufacture a state-branded, low-cost insulin. It still is not here. Stay up-to-date with free briefings on topics that matter to all ...

Gov. Gavin Newsom announced a new $50-million contract with the nonprofit generic drugmaker Civica to produce insulin under the state’s own label during a news conference Saturday in Downey. Under the ...

Lest you think the baby formula shortage occurred overnight or is an isolated problem, think again. It can and will be solved with fewer regulations, a worldwide market, a Trumpian style ...